IBDEI11U ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16865,1,4,0)
 ;;=4^R50.2
 ;;^UTILITY(U,$J,358.3,16865,2)
 ;;=^5019507
 ;;^UTILITY(U,$J,358.3,16866,0)
 ;;=R50.9^^88^881^27
 ;;^UTILITY(U,$J,358.3,16866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16866,1,3,0)
 ;;=3^Fever,Unspec
 ;;^UTILITY(U,$J,358.3,16866,1,4,0)
 ;;=4^R50.9
 ;;^UTILITY(U,$J,358.3,16866,2)
 ;;=^5019512
 ;;^UTILITY(U,$J,358.3,16867,0)
 ;;=R76.11^^88^881^1
 ;;^UTILITY(U,$J,358.3,16867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16867,1,3,0)
 ;;=3^Abnormal Reaction to TB Test w/o Active TB
 ;;^UTILITY(U,$J,358.3,16867,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,16867,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,16868,0)
 ;;=Z21.^^88^881^30
 ;;^UTILITY(U,$J,358.3,16868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16868,1,3,0)
 ;;=3^HIV Asymptomatic,Infection Status
 ;;^UTILITY(U,$J,358.3,16868,1,4,0)
 ;;=4^Z21.
 ;;^UTILITY(U,$J,358.3,16868,2)
 ;;=^5062777
 ;;^UTILITY(U,$J,358.3,16869,0)
 ;;=B37.0^^88^881^16
 ;;^UTILITY(U,$J,358.3,16869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16869,1,3,0)
 ;;=3^Candidal Stomatitis (Oral Thrush)
 ;;^UTILITY(U,$J,358.3,16869,1,4,0)
 ;;=4^B37.0
 ;;^UTILITY(U,$J,358.3,16869,2)
 ;;=^5000612
 ;;^UTILITY(U,$J,358.3,16870,0)
 ;;=B97.10^^88^881^22
 ;;^UTILITY(U,$J,358.3,16870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16870,1,3,0)
 ;;=3^Enterovirus,Unspec,as Cause of Disease
 ;;^UTILITY(U,$J,358.3,16870,1,4,0)
 ;;=4^B97.10
 ;;^UTILITY(U,$J,358.3,16870,2)
 ;;=^5000861
 ;;^UTILITY(U,$J,358.3,16871,0)
 ;;=R50.82^^88^881^24
 ;;^UTILITY(U,$J,358.3,16871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16871,1,3,0)
 ;;=3^Fever,Postprocedural
 ;;^UTILITY(U,$J,358.3,16871,1,4,0)
 ;;=4^R50.82
 ;;^UTILITY(U,$J,358.3,16871,2)
 ;;=^5019509
 ;;^UTILITY(U,$J,358.3,16872,0)
 ;;=R50.83^^88^881^26
 ;;^UTILITY(U,$J,358.3,16872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16872,1,3,0)
 ;;=3^Fever,Postvaccination
 ;;^UTILITY(U,$J,358.3,16872,1,4,0)
 ;;=4^R50.83
 ;;^UTILITY(U,$J,358.3,16872,2)
 ;;=^5019510
 ;;^UTILITY(U,$J,358.3,16873,0)
 ;;=R50.84^^88^881^25
 ;;^UTILITY(U,$J,358.3,16873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16873,1,3,0)
 ;;=3^Fever,Posttransfusion
 ;;^UTILITY(U,$J,358.3,16873,1,4,0)
 ;;=4^R50.84
 ;;^UTILITY(U,$J,358.3,16873,2)
 ;;=^5019511
 ;;^UTILITY(U,$J,358.3,16874,0)
 ;;=B02.23^^88^881^70
 ;;^UTILITY(U,$J,358.3,16874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16874,1,3,0)
 ;;=3^Postherpetic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,16874,1,4,0)
 ;;=4^B02.23
 ;;^UTILITY(U,$J,358.3,16874,2)
 ;;=^266550
 ;;^UTILITY(U,$J,358.3,16875,0)
 ;;=B02.22^^88^881^71
 ;;^UTILITY(U,$J,358.3,16875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16875,1,3,0)
 ;;=3^Postherpetic Trigeminal Neuralgia
 ;;^UTILITY(U,$J,358.3,16875,1,4,0)
 ;;=4^B02.22
 ;;^UTILITY(U,$J,358.3,16875,2)
 ;;=^266546
 ;;^UTILITY(U,$J,358.3,16876,0)
 ;;=J03.91^^88^881^80
 ;;^UTILITY(U,$J,358.3,16876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16876,1,3,0)
 ;;=3^Tonsillitis,Acute Recurrent,Unspec
 ;;^UTILITY(U,$J,358.3,16876,1,4,0)
 ;;=4^J03.91
 ;;^UTILITY(U,$J,358.3,16876,2)
 ;;=^5008136
 ;;^UTILITY(U,$J,358.3,16877,0)
 ;;=K70.0^^88^882^3
 ;;^UTILITY(U,$J,358.3,16877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16877,1,3,0)
 ;;=3^Alcoholic Fatty Liver
 ;;^UTILITY(U,$J,358.3,16877,1,4,0)
 ;;=4^K70.0
 ;;^UTILITY(U,$J,358.3,16877,2)
 ;;=^5008784
 ;;^UTILITY(U,$J,358.3,16878,0)
 ;;=K70.11^^88^882^7
